| ID | Analyse | Domein | Recipiënt | Uitvoering | LTAT (uren (dagen)) | Accred. | LOINC (1) | LOINC (2) | ||
|---|---|---|---|---|---|---|---|---|---|---|
| 24647 | Ratio SARS-CoV-2 S/N IgG Coronavirus 19, COVID-19, Severe Acute Respiratory Syndrome | Serum (2×) |
72 (3) | – | – | – | › | |||
| 28129 | Respiratoire pathogenen Respiratoire micro-organismen panel, Viraal panel | DNA-wisser |
68 (2,8) | – | – | – | › | |||
| 351 | RhD-moleculair | EDTA |
166 (6,9) | – | – | – | › | |||
| 57496 | Rhodium /g creatinine Rh | Urine |
250 (10,4) | – | – | – | › | |||
| 6122 | Risperidone 9-hydroxyrisperidon, 9-hydroxyrisperidone, Invega | Serum |
128 (5,3) | – | – | – | › | |||
| 69862 | Rkn.pt.fRhD genotypering | EDTA |
172 (7,2) | – | – | – | › | |||
| 24574 | Rubella bevestiging | Serum |
20 (0,8) | – | – | – | › | |||
| 57476 | Ruthenium /g creatinine | Urine |
282 (11,7) | – | – | – | › |
